[go: up one dir, main page]

WO2008149668A1 - タンパク質含有組成物 - Google Patents

タンパク質含有組成物 Download PDF

Info

Publication number
WO2008149668A1
WO2008149668A1 PCT/JP2008/059304 JP2008059304W WO2008149668A1 WO 2008149668 A1 WO2008149668 A1 WO 2008149668A1 JP 2008059304 W JP2008059304 W JP 2008059304W WO 2008149668 A1 WO2008149668 A1 WO 2008149668A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
component
molecular weight
composition
containing composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/059304
Other languages
English (en)
French (fr)
Inventor
Kenji Uchida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Publication of WO2008149668A1 publication Critical patent/WO2008149668A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

【課題】長期保存後であっても分子量７５０００～１００００００のタンパク質の変性の程度が少ない経時的安定性の高い組成物を提供すること。 【解決手段】本発明は、下記成分（１）及び（２）を含有する組成物であって、組成物中の成分（２）の含有量が０．７５～１０重量％であり、かつ成分（２）１モルに対して成分（１）の総量が２０～５０モルである組成物を提供する： （１）分子量７５～６８０００のアミノ酸、ペプチド及びタンパク質の少なくとも一種 （２）分子量７５０００～１００００００のタンパク質。
PCT/JP2008/059304 2007-06-07 2008-05-21 タンパク質含有組成物 Ceased WO2008149668A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-152170 2007-06-07
JP2007152170A JP5322405B2 (ja) 2007-06-07 2007-06-07 タンパク質含有組成物

Publications (1)

Publication Number Publication Date
WO2008149668A1 true WO2008149668A1 (ja) 2008-12-11

Family

ID=40093493

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/059304 Ceased WO2008149668A1 (ja) 2007-06-07 2008-05-21 タンパク質含有組成物

Country Status (2)

Country Link
JP (1) JP5322405B2 (ja)
WO (1) WO2008149668A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2011126148A (ru) 2008-11-27 2013-01-10 Шарп Кабусики Кайся Жидкокристаллическое устройство отображения и способ его изготовления
JP5716883B2 (ja) * 2009-06-09 2015-05-13 Jsr株式会社 液晶表示素子の製造方法
JP5621966B2 (ja) * 2009-09-02 2014-11-12 Jsr株式会社 液晶表示素子の製造方法
JP5884258B2 (ja) * 2009-09-18 2016-03-15 Jnc株式会社 液晶配向剤、液晶配向膜、液晶配向膜の製造方法および液晶表示素子
JP2012158615A (ja) * 2012-05-28 2012-08-23 Kobayashi Pharmaceutical Co Ltd 還元糖によるタンパク質変性を抑制する方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS494948B1 (ja) * 1970-12-26 1974-02-04
JPS6430A (en) * 1987-03-24 1989-01-05 Chugai Pharmaceut Co Ltd Gradually releasing preparation
JPH02231037A (ja) * 1988-12-29 1990-09-13 American Home Prod Corp 乳児処方用ランダム化パーム油脂組成物
JPH0499440A (ja) * 1980-12-05 1992-03-31 Schreiber Foods Inc 乳濃縮物
JPH0980051A (ja) * 1995-09-14 1997-03-28 Sanyo Chem Ind Ltd 固相化免疫試薬の安定化溶液
JPH09318628A (ja) * 1996-05-31 1997-12-12 Toray Ind Inc 免疫活性物質の固定化方法
JP2005514017A (ja) * 2001-12-21 2005-05-19 ワイス 多量のアルファ−ラクトアルブミンを含む幼児用処方の組成物
JP2006149371A (ja) * 2004-08-24 2006-06-15 Asama Chemical Co Ltd 乳清タンパク食品

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
WO1990011091A1 (en) * 1989-03-27 1990-10-04 Centocor, Inc. FORMULATIONS FOR STABILIZING OF IgM ANTIBODIES
JPH0565233A (ja) * 1991-03-08 1993-03-19 Mitsui Toatsu Chem Inc モノクローナル抗体含有凍結乾燥製剤
JPH04346934A (ja) * 1991-05-24 1992-12-02 Green Cross Corp:The γ−グロブリンの液状製剤
EP0590060B1 (en) * 1991-06-21 1997-09-17 University Of Cincinnati Orally administrable therapeutic proteins and method of making
WO2004060343A1 (en) * 2002-12-31 2004-07-22 Nektar Therapeutics Antibody-containing particles and compositions

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS494948B1 (ja) * 1970-12-26 1974-02-04
JPH0499440A (ja) * 1980-12-05 1992-03-31 Schreiber Foods Inc 乳濃縮物
JPS6430A (en) * 1987-03-24 1989-01-05 Chugai Pharmaceut Co Ltd Gradually releasing preparation
JPH02231037A (ja) * 1988-12-29 1990-09-13 American Home Prod Corp 乳児処方用ランダム化パーム油脂組成物
JPH0980051A (ja) * 1995-09-14 1997-03-28 Sanyo Chem Ind Ltd 固相化免疫試薬の安定化溶液
JPH09318628A (ja) * 1996-05-31 1997-12-12 Toray Ind Inc 免疫活性物質の固定化方法
JP2005514017A (ja) * 2001-12-21 2005-05-19 ワイス 多量のアルファ−ラクトアルブミンを含む幼児用処方の組成物
JP2006149371A (ja) * 2004-08-24 2006-06-15 Asama Chemical Co Ltd 乳清タンパク食品

Also Published As

Publication number Publication date
JP5322405B2 (ja) 2013-10-23
JP2008303176A (ja) 2008-12-18

Similar Documents

Publication Publication Date Title
WO2008089491A3 (en) Modifications of peptide compositions to increase stability and delivery efficiency
WO2006105112A3 (en) Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people
WO2008043822A3 (en) Amino acid sequences that bind to a desired molecule in a conditional manner
WO2009057775A1 (ja) アミノ酸組成物を含有する疲労防止剤
WO2010000801A3 (de) Molkenproteinhydrolysate enthaltend tryptophanhaltige peptide aus alpha-lactalbumin und deren verwendung
WO2009004315A8 (en) Isolated peptides and uses thereof
WO2008149668A1 (ja) タンパク質含有組成物
WO2008028977A3 (en) Serum albumin binding proteins with long half-lives
WO2010026010A3 (de) Haarbehandlungsmittel mit niedrigdosierten oligopeptiden
WO2007148224A3 (en) Polypeptide
WO2006001023A3 (en) Chimeric proteins and uses thereof
HK1206762A1 (en) Nutritive fragments and proteins with low or no phenylalanine and methods
WO2007097903A3 (en) Hiv fusion inhibitor peptides with improved biological properties
WO2006020720A3 (en) Stable pegylated interferon formulation
WO2007076162A3 (en) Antimicrobial cathelicidin peptides
WO2008081519A1 (ja) 甘味系アミノ酸高含有調味料組成物及びそれを得る酵母
WO2008093058A3 (en) Peptides and their use
NZ606723A (en) Glatiramer acetate molecular weight markers
WO2009064366A3 (en) Methods and compositions for protein labeling using lipoic acid ligases
WO2008105178A1 (ja) リポソーム用生体成分抵抗性増強剤及びこれにより修飾されたリポソーム
EA201070718A1 (ru) Пищевой продукт со стабилизированными небелковыми аминокислотами
WO2010026219A3 (en) New tomato ethylene response factors and uses thereof
WO2005002602A3 (en) Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance
CA2455776A1 (en) Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field
WO2011058315A3 (en) Glucose sensor

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08753031

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08753031

Country of ref document: EP

Kind code of ref document: A1